G1 THERAPEUTICS, INC. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/11ffe688-c303-44c4-b8b5-aa7630bb240f/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $82.5M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-007601 |
| FY 2022 | $51.3M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-005853 |
| FY 2021 | $31.5M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-006299 |
| FY 2020 | $45.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-006299 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
G1 THERAPEUTICS, INC. — all facts · Net Income · Operating Income